Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01474200 · ClinicalTrials.gov registry record · NA
Study of Heart Failure Hospitalizations After Aquapheresis Therapy Compared to Intravenous (IV) Diuretic Treatment
A NA study, sponsored by Nuwellis.
- Terminated
- Registry status
- NA
- Development phase
- 224
- Enrollment target
NCT01474200 is a NA study that was terminated before completion, run by Nuwellis. The registered enrollment target is 224 participants.
The verdict
NCT01474200, a NA study, was terminated before completion, sponsored by Nuwellis.
- TERMINATED
- Registry status
- NA
- Development phase
- 224 participants
- Enrollment target
Study Summary
The purpose of the research is to determine if patients have fewer Heart Failure (HF) events after receiving Aquapheresis (AQ) therapy compared to intravenous (IV) diuretics up to 90 days of discharge from the hospital. Heart Failure events are defined as returning to the hospital, clinic or emergency department (ED) for treatment of HF symptoms.
Interventions
- DEVICE Isolated veno-venous ultrafiltration (AQ)
- DRUG IV Loop Diuretics (LD)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 224 participants |
| Start Date | 2012-01 |
| Est. Completion | 2014-07 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01474200
The ClinicalTrials.gov registry entry for NCT01474200 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 224 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Nuwellis, which has 7 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Isolated veno-venous ultrafiltration (AQ) is the first listed.
NCT01474200 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01474200 about?
NCT01474200 is a clinical study titled "Study of Heart Failure Hospitalizations After Aquapheresis Therapy Compared to Intravenous (IV) Diuretic Treatment". The purpose of the research is to determine if patients have fewer Heart Failure (HF) events after receiving Aquapheresis (AQ) therapy compared to intravenous (IV) diuretics up to 90 days of discharge from the hospital. Heart Failure events are defined as returning to the hospital, clinic or emergen...
What is the current status of trial NCT01474200?
This trial is currently terminated. It is a NA study. The enrollment target is 224 participants. The study started on 2012-01. Estimated completion is 2014-07.
What interventions are being tested in trial NCT01474200?
The interventions under investigation include: Isolated veno-venous ultrafiltration (AQ) (DEVICE), IV Loop Diuretics (LD) (DRUG).
Who is sponsoring clinical trial NCT01474200?
This trial is sponsored by Nuwellis, which has 7 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.